Centra Pharmacy Northway Pharmacy Location: 1555 Northway Drive, St Cloud, Minnesota 56303 Phone: (320) 240-3160 |
Healthnorth Medical Supply Company Durable Medical Equipment & Medical Supplies Location: 1320 North 32nd Avenue, St Cloud, Minnesota 56303 Phone: (320) 281-5311 |
St Cloud Foot And Ankle Center Pa Medicare Supplier Location: 106 Doctors Park, St Cloud, Minnesota 56303 Phone: (320) 251-5444 |
News Archive
Research by psychologists at the University of Kent has found that a majority of people would endorse the use of revenge porn and that those who actually post it have a distinct personality profile.
Scientists have identified a strain of antibiotic-resistant tuberculosis that thrives in the presence of rifampin, a front-line drug in the treatment of tuberculosis. The bacterium was identified in a patient in China and is described in a study by researchers at the Johns Hopkins Bloomberg School of Public Health, Chongqing Pulmonary Hospital, Lanzhou University and Fudan University.
Boehringer Ingelheim Pharma GmbH & Co. KG, an international research-driven pharma company, and Eurofins Medigenomix GmbH, a competence center for genetic analyses of the Eurofins Scientific Group, concluded a long-term service agreement in the area of DNA banking, as well as a master service agreement for pharmacogenetic and pharmacogenomic services. For DNA banking Eurofins Medigenomix is supporting operations of Boehringer Ingelheim's central DNA bank at Biberach an der Riss.
Vascular Solutions, Inc. today announced that it has acquired the assets related to the EXPRO Elite™ and MICRO Elite™ snare products from Radius Medical Technologies, Inc. and its subsidiary, Radius Medical, LLC. Vascular Solutions has been selling the EXPRO Elite™ and MICRO Elite™ snares in the U.S. under a distribution relationship with Radius since 2008, while in international markets Radius has been selling the products through a network of independent distributors.
ytRx Corporation, a biopharmaceutical company, today announced favorable preliminary results from its Phase 2 STAR-1 registration clinical trial for tamibarotene in the treatment of acute promyelocytic leukemia (APL) in patients failing other treatments.
› Verified 5 days ago